Herman Bril
Impact in
- Oncology top 10%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Immunology 21
- Immunotherapy and Immune Responses 16
- Immune Cell Function and Interaction 16
- T-cell and B-cell Immunology 12
- Immune Response and Inflammation 3
- Oncology 10
- Co-authors
- Hein B.A.C. Stockmann (19 shared papers)Gerrit A. Meijer (17 shared papers)Eric J.T. Belt (13 shared papers)Remond J.A. Fijneman (11 shared papers)Jeroen A.M. Beliën (6 shared papers)Pien M. Delis‐van Diemen (9 shared papers)R. Benner (14 shared papers)Marianne Tijssen (5 shared papers)
- Journals
- Transplantation (4 papers)Annals of Surgical Oncology (4 papers)Cellular Immunology (3 papers)Oncotarget (3 papers)Cancer Immunology Immunotherapy (2 papers)
- Partner nations
- NetherlandsUnited StatesDenmark
In The Last Decade
Herman Bril
55 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Oncology 321
- Immunology 228
- Cancer Research 129
- Pathology and Forensic Medicine 136
- Rheumatology 69
Countries citing papers authored by Herman Bril
This map shows the geographic impact of Herman Bril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herman Bril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herman Bril more than expected).
Fields of papers citing papers by Herman Bril
This network shows the impact of papers produced by Herman Bril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herman Bril. The network helps show where Herman Bril may publish in the future.
Co-authors
The 25 scholars most cited alongside Herman Bril, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 103 | |
| 2 | 1993 | 103 | |
| 3 | 2010 | 77 | |
| 4 | 2011 | 71 | |
| 5 | 2011 | 57 | |
| 6 | 2011 | 54 | |
| 7 | 2013 | 50 | |
| 8 | 2012 | 47 | |
| 9 | 2015 | 43 | |
| 10 | 2013 | 41 | |
| 11 | 2015 | 39 | |
| 12 | 2013 | 37 | |
| 13 | 2016 | 32 | |
| 14 | 2012 | 31 | |
| 15 | 2014 | 30 | |
| 16 | 1981 | 28 | |
| 17 | 1983 | 25 | |
| 18 | 2019 | 20 | |
| 19 | 1993 | 17 | |
| 20 | 1991 | 16 |
About Herman Bril
Herman Bril is a scholar working on Immunology, Oncology, Molecular Biology, Pathology and Forensic Medicine and Surgery, having authored 57 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (12 papers), Cytomegalovirus and herpesvirus research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Biochemical and Molecular Research (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Oncology (321 citations), Immunology (228 citations), Cancer Research (129 citations), Pathology and Forensic Medicine (136 citations) and Rheumatology (69 citations). Herman Bril has collaborated with scholars based in Netherlands, United States and Denmark. Frequent co-authors include Hein B.A.C. Stockmann, Gerrit A. Meijer, Eric J.T. Belt, Remond J.A. Fijneman, Jeroen A.M. Beliën, Pien M. Delis‐van Diemen, R. Benner, Marianne Tijssen, Elly S.M. de Lange–de Klerk and A.T.J. Bianchi. Their work appears in journals such as Transplantation, Annals of Surgical Oncology, Cellular Immunology, Oncotarget and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.